04:16 PM EDT, 08/22/2024 (MT Newswires) -- Carole Ho, Chief Medical Officer, on August 20, 2024, sold 22,458 shares in Denali Therapeutics ( DNLI ) for $549,928. Following the Form 4 filing with the SEC, Ho has control over a total of 327,029 shares of the company, with 118,810 shares held directly and 208,219 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1714899/000171489924000194/xslF345X05/wk-form4_1724357642.xml